Aptera Motors Corp
For the period ended Mar 31, 2026. Filed May 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 13, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Condensed Consolidated Financial Statements (Unaudited)
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1—ORGANIZATION AND BUSINESS
Aptera Motors Corp. (“Aptera” the “Company,” “we,” “us” or “our” and similar terms refers to Aptera Motors Corp. and its subsidiaries unless the context otherwise requires) was incorporated on March 4, 2019 (“Inception”) in the State of Delaware. The Company is developing a solar electric vehicle focused on efficiency. In September 2023, the Company established the subsidiary company Aptera Motors Italia Srl, based in Modena, Italy.
Risks and Uncertainties
Our business is highly sensitive to domestic and global economic and business conditions as well as local, state, and federal government policy decisions. Several factors beyond our control could cause material fluctuations in our business and financial condition. In addition, we require a significant amount of capital to fund vehicle manufacturing, have a limited operating history and operate with small management and development teams that contain key employees. We also face significant barriers to market entry and competing technologies. At times, we have experienced constraints and volatility in our supply chain that resulted in increased costs to us. Furthermore, we are affected by uncertain regulatory conditions, fluctuations in demand, and inflation in production and shipping costs. These conditions could affect the volatility of our business, our financial condition and our results of operations.
Going Concern and Management’s Plans
We have incurred losses from operations since inception and have not generated any revenue to date. We expect to incur significant costs associated with vehicle development, testing, and the commencement of production before generating revenue. As of March 31, 2026, our existing cash and cash equivalents were not sufficient to fund our current operations for the next twelve months. These factors, among others, raise substantial doubt about our ability to continue as a going concern.
Management is executing a multi-phased financial strategy to address our liquidity needs and fund our path to production. Significant milestones achieved include:
| ● | Nasdaq Direct Listing: On October 16, 2025, our Class B Common Stock commenced trading on the Nasdaq Capital Market under the ticker symbol “SEV,” providing a platform for broader access to public capital markets. |
| ● | Equity Line of Credit (“ELOC”): In October 2025, we entered into a share purchase agreement providing a committed $75 million equity line of credit. Between mid-November and December 2025, we successfully utilized this facility to raise approximately $3.0 million in gross proceeds. |
| ● | January 2026 Capital Raise: In January 2026, the Company successfully raised an additional $9 million ($8.2 million, net of direct offering expenses) through the issuance of common stock and warrants. |
| ● | March 2026 Warrant Exercises: During the first quarter of 2026, the Company received aggregate gross cash proceeds of approximately $8.1 million from warrant exercises, which included a $6.3 million warrant inducement transaction completed on March 12, 2026. |
Our ability to continue as a going concern is dependent on our ability to obtain sufficient funding by accessing the remaining capacity under our $75 million ELOC and raising additional capital through public or private markets. Following the successful capital raises in early 2026, management estimates that an additional $45 million to $50 million is required to fund the initial low-volume production phase of our Carlsbad facility.
While management believes our access to the public markets and the ELOC provide a viable path to necessary liquidity, there is no guarantee that we will be able to draw down sufficient amounts or secure additional financing on favorable terms. If we are unable to obtain adequate financing, we may be required to implement significant cost-cutting measures or significantly curtail our operations. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
NOTE 2 –BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation and Principles of Consolidation
The accompanying condensed consolidated financial statements included herein have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted as permitted by such rules and regulations; however, the Company believes the disclosures are adequate to make the information presented not misleading.
The interim financial information is unaudited, but reflects all normal recurring adjustments that are, in the opinion of management, necessary to fairly present the information set forth herein. The interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2025 included in Form 10-K recently filed with the SEC. Interim results are not necessarily indicative of the results expected for the full year.
The Company operates as a single reportable segment focused on the development of solar electric vehicles. The Co-Chief Executive Officers review consolidated financial information to assess performance and allocate resources.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of expenses during the reporting periods. We use historical and other pertinent information to determine those estimates. Actual results could materially differ from these estimates.
Reverse Stock Split
The accompanying condensed consolidated financial statements and related notes have been retroactively restated to reflect a 1-for-3 reverse stock split of the Company’s common stock effected on August 5, 2025.
Fair Value of Financial Instruments
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants as of the measurement date. Applicable accounting guidance provides an established hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors that market participants would use in valuing the asset or liability. There are three levels of inputs that may be used to measure fair value:
Level 1—Quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.
Level 2—Observable inputs other than prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated with observable market data.
Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities. This includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.
The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
Fair-value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of the balance sheet dates.
The following are the classes of assets and liabilities measured at fair value:
| Description · Level 1 · Level 2 · Level 3 · Total | ||||||
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Money market fund | $10,764 | $ | - | $ | - | $10,764 |
| Total | $10,764 | $ | - | $ | - | $10,764 |
| Description · Level 1 · Level 2 · Level 3 · Total | ||||||
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Money market fund | $4,799 | $ | - | $ | - | $4,799 |
| Total | $4,799 | $ | - | $ | - | $4,799 |
As of March 31, 2026 and December 31, 2025, the respective carrying value of cash and cash equivalents, receivables, other current assets, accounts payable, unearned reservation fees and short-term debt approximated their fair values.
Cash and Cash Equivalents
The Company considers all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents. As of March 31, 2026 and December 31, 2025, cash and cash equivalents contained $4.1 million of unearned refundable customer reservation fees.
Property and Equipment
Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the following estimated useful lives:
| Computers, hardware and software | 3 years |
|---|---|
| Leasehold improvements | shorter of remaining lease term or 5 years |
| Research and development equipment | 5 years |
| Other equipment | 5 years |
Long-Lived Assets
Long-lived assets, such as property, plant and equipment and operating lease assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for potential impairment, we first compare undiscounted cash flows expected to be generated by that asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent the carrying amount of the underlying asset exceeds its fair value.
Unearned Reservation Fees
Unearned reservation fee liabilities are recorded based on all funds we expect to collect on each transaction, including merchant processor fees charged. We maintain a separate money market account for all customer reservation fees collected.
Leases
The Company recognizes all operating leases on the condensed consolidated balance sheets at the commencement date. This includes:
| ● | A right-of-use (ROU) asset representing the right to use the leased asset. |
| ● | A lease liability representing the future lease payments discounted to present value. |
Lease expense is recognized on a straight-line basis over the lease term, reflecting the benefit of using the leased asset. Our assessed lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option.
We recognize a ROU asset at the commencement of an operating lease, representing the right to use the leased asset. The ROU asset is initially measured at the present value of the non-cancellable lease payments, including any initial direct payments. The ROU asset is depreciated over the lease term, using the same depreciation method and useful life as the underlying leased asset, or if not readily determinable, using a straight-line method over the lease term.
We recognize a lease liability at the commencement of an operating lease, representing the obligation to make lease payments. The lease liability is initially measured at the present value of the non-cancellable lease payments, less any initial direct payments. The lease liability is subsequently remeasured to reflect the present value of the remaining lease payments using the lessee’s incremental borrowing rate at the initial recognition date or the subsequent remeasurement date, if applicable. Interest expense is recognized on the lease liability using the effective interest method.
Commitments and Contingencies
Liabilities for loss contingencies arising from claims, assessments, litigation, fines, and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount within a range of loss can be reasonably estimated. When no amount within the range is a better estimate than any other amount, we accrue for the minimum amount within the range. Legal costs incurred in connection with loss contingencies are expensed as incurred.
We regularly enter into purchase obligations with vendors and service providers, which represent expected payments and commitments during the normal course of our business. These purchase obligations are generally cancellable with or without notice and without penalty, although certain vendor agreements provide for cancellation fees or penalties. As of March 31, 2026 and December 31, 2025, we had approximately $2.2 and $2.1 million in open purchase orders, respectively.
Revenue Recognition
To date, the Company has not generated any revenue from operations. The Company is currently in the pre-production development, testing and validation stage.
The Company expects to recognize revenue upon the delivery of its product to customers.
The Company’s ability to generate revenue is subject to various risks and uncertainties, including successful product development, market acceptance and regulatory approvals. These factors could materially impact the timing and amount of future revenue recognized by the Company.
Key Considerations for Future Revenue Recognition:
| ● | Performance obligations: The Company will assess its contracts with customers to identify the distinct performance obligations and allocate the transaction price accordingly. |
| ● | Variable consideration: If applicable, the Company will estimate the amount of variable consideration to which it is entitled based on the probability-weighted approach. |
| ● | Right of return: If customers have a right to return products, the Company will recognize a refund liability and adjust revenue accordingly. |
| ● | Principal versus agent: The Company will determine whether it acts as a principal or an agent in its transactions, which will impact the presentation of revenue in the financial statements. |
The Company will continue to evaluate its revenue recognition policies and procedures as its business evolves and will make any necessary disclosures in future financial statements.
Advertising Costs
The Company expenses advertising and promotional costs as incurred. Advertising costs are included within selling, general, and administrative expenses in the accompanying consolidated statements of operations. Advertising expenses were $0.15 million and $0.41 million for the three months ended March 31, 2026 and 2025, respectively.
Income Taxes
The Company provides for income taxes using the asset and liability approach. As of March 31, 2026, the Company continues to maintain a full valuation allowance against its net deferred tax assets, as management believes it remains more likely than not that they will not be realized. There have been no material changes to the Company’s liability for uncertain tax positions since December 31, 2025.
Stock-Based Compensation
The Company measures and recognizes compensation expense for all stock-based awards, including stock options and restricted stock units (“RSUs”), granted to employees, directors, and non-employees based on their estimated grant-date fair value.
| ● | Stock Options: The fair value of stock options is estimated at the date of grant using the Black-Scholes option-pricing model. |
| ● | Restricted Stock Units: The fair value of RSUs is determined based on the closing market price of the Company’s Class B Common Stock on the date of grant. |
The Company accounts for forfeitures as they occur. Accordingly, compensation expense is recognized only for awards that ultimately vest. Forfeitures are recognized in the period in which they occur, and no estimations or adjustments are made for anticipated forfeitures.
Research and Development
Research and development costs are expensed as incurred and represent costs incurred to further new technologies, product design and technical capabilities.
Concentration of Credit Risk
Financial instruments that potentially subject us to concentration of credit risk are cash, cash equivalents, and restricted cash. We hold cash in domestic financial institutions that are federally insured within statutory limits. At times, deposits exceed federally insured limits.
Concentration of Supply Risk
The Company is dependent on a few suppliers for capital equipment, the majority of which are single-source suppliers, and the inability of these suppliers to deliver necessary equipment and components of its products according to the schedule and at prices, quality levels and volumes acceptable to the Company, or its inability to efficiently manage these components, could have a material adverse effect on the Company’s results of operations and financial condition.
Loss Per Share
We compute net loss per share of Class A and Class B Common Stock using the two-class method. Basic net loss per share is computed using the weighted-average number of shares outstanding during the period. Diluted net loss per share is computed using the weighted-average number of shares and the effect of potentially dilutive securities outstanding during the period. For periods in which we incur a net loss, the effects of potentially dilutive securities would be antidilutive and would be excluded from diluted calculations. Dilutive securities consist of Preferred Stock, restricted stock units, stock options and warrants issued under the Company’s Equity Incentive Plans.
Potentially dilutive securities outstanding were as follows:
| March 31, 2026 | March 31, 2025 | |
|---|---|---|
| Preferred stock | - | 3,721,394 |
| Restricted stock units | 402,498 | - |
| Stock options | 6,440,255 | 3,678,890 |
| Warrants | 6,188,337 | 868,167 |
| Potentially dilutive securities | 13,031,090 | 8,268,451 |
For the three months ended March 31, 2026 and 2025, we incurred a net loss for which the effects of our potentially dilutive securities would be antidilutive and are therefore excluded from diluted net loss per share calculations.
The following table sets forth the computation of basic net loss per share of Class A and Class B stock (in thousands, except per share amounts):
| Three Months Ended March 31, | ||||
|---|---|---|---|---|
| 2026 | 2025 | |||
| Class A | Class B | Class A | Class B | |
| Numerator: | ||||
| Allocation of losses | $(3,874) | $(6,320) | $(8,594) | $(2,273) |
| Denominator: | ||||
| Weighted average shares outstanding | 12,215,600 | 19,930,236 | 18,486,999 | 4,890,205 |
| Basic net loss per share | (0.32) | (0.32) | (0.46) | (0.46) |
Recent Accounting Pronouncements
In November 2024, the FASB issued ASU 2024-03,Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40), which requires public business entities to disclose specific natural expense categories within relevant expense captions. The standard is effective for annual reporting periods beginning after December 15, 2026. The Company is currently evaluating the impact of this standard on its financial statement disclosures.
In December 2025, the FASB issued ASU 2025-11,Interim Reporting (Topic 270): Narrow-Scope Improvements, which is intended to improve the guidance in Topic 270 by enhancing the navigability of required interim disclosures and clarifying the applicability of the guidance. The update also introduces a disclosure principle requiring the disclosure of events occurring since the end of the most recent annual reporting period that have a material impact on the entity. For the Company, the standard is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. The Company is currently evaluating the impact of this standard on its financial statement disclosures.
NOTE 3 –COMMITMENTS AND CONTINGENCIES
Litigation and Regulation
Various aspects of our business and service areas are subject to U.S. federal, state, and local regulation, as well as regulation outside the United States. The Company is also subject to legal proceedings which arise in the ordinary course of business.
In August 2024, Zaptera USA, Inc. (“Zaptera”) filed a complaint against Aptera Motors Corp. in the U.S. District Court for the Southern District of California alleging design patent infringement, misappropriation of trade secrets, and declaratory judgment of patent ownership, among other claims.
In April 2026, the Company entered into a settlement agreement with Zaptera. Pursuant to the terms of the settlement, the Company agreed to issue 105,000 shares of Class B Common Stock and warrants to purchase up to 210,000 shares of Class B Common Stock at an exercise price of $2.78 expiring on April 8, 2029. As a result of the settlement, the Company accrued liability and recognized litigation expense equivalent to the estimated fair value of the settlement of approximately $0.6 million as of March 31, 2026 which is included in “Accrued liabilities” in the condensed consolidated balance sheets and “General, selling, and administrative” in the condensed consolidated statements of operations. On April 9, 2026, all claims related to the action were dismissed with prejudice.
In January 2025, the Company received a subpoena for documents from the staff of the Securities and Exchange Commission (SEC) related to its securities offerings and the production, design, and manufacture of our vehicles. This subpoena is part of an ongoing SEC investigation. The Company continues to cooperate fully with the investigation and is continuing to produce documents in response to the subpoena and subsequent requests.
The SEC has informed us that the investigation does not mean that it has concluded that anyone has violated the law and that the receipt of the subpoena does not mean that the SEC has a negative opinion of any person, entity, or security. However, the Company can offer no assurances as to the timing, outcome or potential effect, if any, of this ongoing investigation. Responding to the subpoena and related requests continues to require the dedication of management time and attention and has resulted, and may continue to result, in the incurrence of significant expenses, including legal and other professional services fees.
NOTE 4 –LEASES
The Company leases approximately 77,000 rentable square feet of office, manufacturing, and assembly space at its principal facility in Carlsbad, California.
During the three months ended March 31, 2026, the Company executed an amendment to extend the lease term for this facility by an additional twelve months, establishing a new expiration date of March 31, 2028. The amendment established a revised monthly base rent of approximately $106,000 during the extension period and eliminated the Company’s previously existing options to extend the lease for two additional 60-month periods. Additionally, the amendment stipulates that $0.7 million of the Company’s existing security deposit will be applied toward monthly base rent payments commencing April 1, 2027, reducing the held deposit to $0.3 million over time.
As a result of this lease modification, the Company remeasured its lease liability and corresponding right-of-use (ROU) asset based on an updated incremental borrowing rate of 9.75%. This remeasurement resulted in an increase of $1.1 million to both the operating lease ROU asset and operating lease liability.
The following table presents supplemental information related to the Company’s operating lease:
| As of March 31, 2026 | As of December 31, 2025 | |
|---|---|---|
| Supplemental lease information: | ||
| Weighted average remaining lease term (in years) | 2.0 | 1.25 |
| Weighted average discount rate | 9.75% | 8.30% |
Maturities of operating lease liabilities as of March 31, 2026, are as follows:
The following table summarizes the annual contractual maturities of operating lease liabilities (in thousands):
| 2026 (remaining 9 months) | $950 |
| 2027 | 1,268 |
| 2028 | 316 |
| Total minimum lease payments | 2,534 |
| Imputed interest | (221) |
| Present value of lease liabilities | $2,313 |
The Company recorded $0.3 million as operating lease expense for the three months ended March 31, 2026 and 2025, respectively. This expense is allocated to “General, selling, and administrative” and “Research and development” expenses in the condensed consolidated statements of operations.
NOTE 5 –STOCKHOLDERS’ EQUITY
Common Stock
The Company’s authorized capital stock includes Class A Common Stock and Class B Common Stock. The rights of the holders of both classes are identical, including rights to dividends and distributions upon liquidation, except with respect to voting and conversion. Holders of Class A Common Stock are entitled to one vote per share on all matters submitted to a vote of stockholders, while holders of Class B Common Stock are not entitled to voting rights, except as required by applicable law. Additionally, each share of Class A Common Stock is convertible at any time, at the option of the holder, into one share of non-voting Class B Common Stock on a one-for-one basis.
January 2026 Public Offering
On January 26, 2026, the Company closed a registered public offering, issuing 4,500,000 shares of Class B common stock and accompanying common stock warrants to purchase up to 4,500,000 shares of Class B common stock (“Existing Warrants”). The combined public offering price was $2.00 per share and accompanying warrant, resulting in gross proceeds of approximately $9.0 million, before deducting placement agent fees and other offering expenses of approximately $0.8 million. The warrants were issued with an exercise price of $2.00 per share, became exercisable immediately, and expire five years from the issuance date.
March 2026 Warrant Inducement
On March 12, 2026, the Company entered into a warrant inducement agreement with certain holders of the warrants previously issued in the January 2026 public offering. Pursuant to the agreement, the holders exercised Existing Warrants to purchase 3,167,500 shares of Class B common stock for gross cash proceeds of approximately $6.3 million, before deducting placement agent fees and other offering expenses of approximately $0.4 million. As consideration for the immediate cash exercise of these warrants, the Company issued new, unregistered warrants to purchase up to 4,751,250 shares of Class B common stock (“New Warrants”). The New Warrants have an exercise price of $3.50 per share, are immediately exercisable, and expire five years from the date of issuance.
The Company estimated the fair value of the New Warrants and the Existing Warrants tendered for exercise on the modification date using the Black-Scholes-Merton option pricing model, with an underlying stock price of $2.68 (the closing price of the Company’s Class B Common Stock on the modification date), expected volatility of 90.37% (based on the historical volatility of a peer group of publicly traded companies), a risk-free interest rate of 3.88% (based on the U.S. Treasury constant-maturity yield commensurate with the expected term), an expected dividend yield of 0%, and an expected term equal to the remaining contractual life of each instrument (5.00 years for the New Warrants and 4.87 years for the Existing Warrants). The aggregate fair value of the 4,751,250 New Warrants at issuance was approximately $8.6 million, and the aggregate fair value of the 3,167,500 Existing Warrants immediately before exchange was approximately $6.4 million. The resulting inducement consideration of approximately $4.4 million was recognized as a non-cash equity issuance cost. As both warrant series were determined to be equity-classified, the inducement transaction had no net impact on total stockholders’ equity and no impact on the condensed consolidated statement of operations for the three months ended March 31, 2026.
Warrant Activity
The following table summarizes the Company’s warrant activity for the three months ended March 31, 2026:
| Warrants | Weighted average exercise price | Weighted Average remaining contractual term | |
|---|---|---|---|
| Balance at December 31, 2025 | 866,667 | $15.36 | 8.6 |
| Issued | 9,386,250 | 2.77 | 4.9 |
| Exercised | (4,064,580) | 2.00 | 4.8 |
| Expired | - | - | - |
| Outstanding and exercisable at March 31, 2026 | 6,188,337 | 5.09 | 5.5 |
Equity Line of Credit (ELOC)
In October 2025, the Company entered into a Share Purchase Agreement with New Circle Principal Investments LLC, providing the Company with the right, but not the obligation, to sell up to $75.0 million of its Class B Common Stock over a 36-month period. Shares are sold at the Company’s discretion at a purchase price based on the Volume Weighted Average Price (VWAP) during a specified pricing period, less a negotiated discount.
The Company’s ability to access capital under the ELOC is subject to the following primary constraints:
| ● | Exchange Cap: Total shares issued under the facility cannot exceed 19.99% of the shares outstanding as of October 13, 2025, unless stockholder approval is obtained or is not required under applicable Nasdaq rules. |
| ● | Ownership Cap: The investor cannot beneficially own more than 4.99% (or 9.99% upon notice) of the Company’s outstanding Class B Common Stock at any given time. |
| ● | Registration Requirement: Accessing the facility requires the Company to maintain an effective resale registration statement covering the shares. |
In connection with the January 2026 Public Offering, the Company’s utilization of the ELOC became subject to a 45-day lock-up period, which expired on March 12, 2026. During the three months ended March 31, 2026, the Company did not sell shares of Class B Common Stock under the ELOC. As of March 31, 2026, $72.0 million remained available for future utilization under the facility.
NOTE 6 –STOCK-BASED COMPENSATION
Equity Incentive Plans
The Company maintains the 2025 Omnibus Equity Incentive Plan (the “2025 Plan”), which allows for the grant of various equity-based awards to employees, officers, directors, and consultants. As of March 31, 2026,11,258,775 shares of Class B Common Stock remained available for future issuance under the 2025 Plan. Although the 2021 Stock Option and Incentive Plan was terminated in October 2025, outstanding awards under that plan remain in effect according to their original terms.
Stock Option Activity
A summary of stock option activity for the three months ended March 31, 2026, is as follows (aggregate intrinsic values in thousands):
| Options | Weighted average exercise price | Aggregate Intrinsic value | Weighted average grant date fair value | Weighted average remaining contractual Term | |
|---|---|---|---|---|---|
| Balance at December 31, 2025 | 6,652,405 | $15.54 | - | $14.13 | 7.72 |
| Granted | - | - | - | - | - |
| Forfeited | - | - | - | - | - |
| Expired | (212,150) | 13.96 | - | 22.92 | - |
| Outstanding and expected to vest at March 31, 2026 | 6,440,255 | 15.59 | - | 13.84 | 7.72 |
| Vested and exercisable at March 31, 2026 | 3,503,314 | 19.71 | - | 16.54 | 6.29 |
There were no options granted during the three months ended March 31, 2026 and 2025. The total fair value of stock options vested during the three months ended March 31, 2026 and 2025 was approximately $2.4 million and $0.9 million, respectively.
We estimate the fair value of the options utilizing the Black-Scholes option pricing model, which is dependent upon several variables, including expected option term, expected volatility of our share price over the expected term, expected risk-free interest rate, and the underlying estimated fair value of our common stock. There were no options issued during the three months ended March 31, 2026 and 2025.
The Company utilizes the Black-Scholes option-pricing model to estimate the fair value of stock options on the date of grant. The expected term is estimated using the simplified method, and expected volatility is based on the historical volatility of a peer group of publicly traded companies.
Restricted Stock Unit Activity
A summary of restricted stock unit activity for the three months ended March 31, 2026 is as follows:
| Number of Shares | Weighted Average Grant Date Fair Value | |
|---|---|---|
| Nonvested at December 31, 2025 | 381,414 | $5.10 |
| Granted | 43,197 | 4.63 |
| Vested | (51,486) | 4.94 |
| Forfeited | - | - |
| Nonvested at March 31, 2026 | 373,125 | 5.51 |
| Vested not yet issued at March 31, 2026 | 29,373 | 6.98 |
The total fair value of RSUs granted and vested during the three months ended March 31, 2026 was approximately $0.2 million and $0.2 million, respectively. There wereno RSUs granted or vested during the three months ended March 31, 2025.
Allocation of Stock-based Compensation
The allocation of stock-based compensation expense was as follows (in thousands):
| For the three months ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| General, selling and administrative | $1,340 | $5,287 |
| Research and development | 2,016 | 788 |
| Total stock-based compensation | $3,356 | $6,075 |
As of March 31, 2026, the total unrecognized compensation cost related to outstanding time-based options was $31 million, which is expected to be recognized over a weighted-average period of 2.9 years.
NOTE 7 –SUBSEQUENT EVENTS
The Company evaluated subsequent events from the balance sheet date of March 31, 2026, through May 13, 2026, the date these condensed consolidated financial statements were issued. Material events include:
Zaptera Litigation Settlement
On April 8, 2026, the Company entered into a settlement agreement with Zaptera USA, Inc. Pursuant to the terms of the settlement, the Company agreed to issue 105,000 shares of Class B Common Stock and warrants to purchase up to 210,000 shares of Class B Common Stock. The approximately $0.6 million settlement expense was accrued in the three months ended March 31, 2026.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.